Mengji Lu

2.7k total citations
5 papers, 165 citations indexed

About

Mengji Lu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mengji Lu has authored 5 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Mengji Lu's work include Liver Disease Diagnosis and Treatment (2 papers), Thyroid and Parathyroid Surgery (1 paper) and Glycosylation and Glycoproteins Research (1 paper). Mengji Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (2 papers), Thyroid and Parathyroid Surgery (1 paper) and Glycosylation and Glycoproteins Research (1 paper). Mengji Lu collaborates with scholars based in China, Germany and Romania. Mengji Lu's co-authors include Arnold Radtke, Hartmut Schmidt, Lei‐Bo Xu, Gernot M. Kaiser, Chao Liu, Susanne Beckebaum, Iyad Kabar, Vito R. Cicinnati, Xiaoyong Zhang and Speranța Iacob and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hepatology and Journal of Immunological Methods.

In The Last Decade

Mengji Lu

4 papers receiving 164 citations

Peers

Mengji Lu
Comparison fields: 5 of 34
  • Cancer Research 106
  • Molecular Biology 101
  • Epidemiology 50
  • Oncology 19
  • Hepatology 16
Replace Diannan Xu with:
Diannan Xu China
Shuyi Qi China
Rongli Wei China
Dongning Rao China
Sheina Piyanzin Israel
Zhixiong Long China
Ajay Nair India
Sobia Zaidi United States
Chinami Makii Japan
Dikla Atias Israel
Diannan Xu China View profile →
Citations per field, relative to Mengji Lu
Mengji Lu · 1×
Citations per year, relative to Mengji Lu
Mengji Lu · 1×

Countries citing papers authored by Mengji Lu

Since Specialization
Citations

This map shows the geographic impact of Mengji Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengji Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengji Lu more than expected).

Fields of papers citing papers by Mengji Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengji Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengji Lu. The network helps show where Mengji Lu may publish in the future.

Co-authorship network of co-authors of Mengji Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengji Lu. A scholar is included among the top collaborators of Mengji Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengji Lu. Mengji Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
# Work Indexed citations
1 7
2 138
3 4
4
[Preparation and identification of polyclonal antibody against protein H1b: the variant of major subunit of human ASGPR].
0
5 16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026